Rankings
▼
Calendar
RGEN Q2 2021 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q2 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$163M
+86.3% YoY
Gross Profit
$101M
62.0% margin
Operating Income
$48M
29.6% margin
Net Income
$36M
22.2% margin
EPS (Diluted)
$0.64
QoQ Revenue Growth
+14.1%
Cash Flow
Operating Cash Flow
$38M
Free Cash Flow
$20M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$2.0B
Total Liabilities
$413M
Stockholders' Equity
$1.6B
Cash & Equivalents
$734M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$163M
$87M
+86.3%
Gross Profit
$101M
$51M
+99.5%
Operating Income
$48M
$20M
+146.9%
Net Income
$36M
$16M
+128.4%
Revenue Segments
Product
$163M
100%
Royalty
$40,000
0%
← FY 2021
All Quarters
Q3 2021 →